Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retigabine effects on cortical inhibition measured by TMS in focal epilepsy
NL-OMON37062Not yet recruiting
- Sponsor
- Kempenhaeghe
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of retigabine in Focal Onset Epilepsy, sponsored by Kempenhaeghe. Primary endpoints: Change in intracortical facilitation and Change in silent period. Planned start Feb 2013; status: not yet recruiting.
02
Drugs
retigabine
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on NL-OMON37062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37062.